Approved on November 5th 2009 was Romidepsin (trade name Istodax). Romidepsin, previously known by the research codes FK-228, FR-901228 and NSC-630176, is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous T-cell lymphoma (CTCL)…
Read the full story here...
Reactor headlines and excerpts on the Reactive Reports chemistry blog are brought to you courtesy of the excellent Chemical Blogspace latest posts feed. You can subscribe directly to the Cb site here to receive updates on chemistry news, lab talk, and much more from a wide range of chemistry bloggers covering all the chemical sciences.
If you're lucky, the following quote may be relevant in some way to the post above, but then again...

Popular Posts